Use of18F-FDG PET to predict tumor progression and survival in patients with intermediate hepatocellular carcinoma treated by transarterial chemoembolization-Reference-Cited by-同舟云学术

Use of18F-FDG PET to predict tumor progression and survival in patients with intermediate hepatocellular carcinoma treated by transarterial chemoembolization

Published:2015 Issue:3 Volume:30 Page:308
ISSN:1226-3303
Container-title:The Korean Journal of Internal Medicine
language:en
Short-container-title:Korean J Intern Med

Author:

Kim Min Jin¹,Kim Young Seok¹,Cho Youn Hee¹,Jang Hee Yoon¹,Song Jeong-Yeop¹,Lee Sae Hwan¹,Jeong Soung Won¹,Kim Sang Gyune¹,Jang Jae Young¹,Kim Hong Su¹,Kim Boo Sung¹,Lee Won Hyung²,Park Jung Mi²,Lee Jae Myung³,Lee Min Hee³,Choi Deuk Lin⁴

Affiliation:

1. Digestive Disease Center and Research Institute, Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Bucheon, Korea.

2. Department of Nuclear Medicine, Soonchunhyang University Bucheon Hospital, Bucheon, Korea.

3. Department of Radiology, Soonchunhyang University Bucheon Hospital, Bucheon, Korea.

4. Department of Radiology, Soonchunhyang University Hospital, Seoul, Korea.

Publisher

Korean Association of Internal Medicine

Link

http://synapse.koreamed.org/pdf/10.3904/kjim.2015.30.3.308

Reference27 articles.

1. Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose

2. The role of SPET and PET in monitoring tumour response to therapy